CHGCY Chugai Pharmaceutical Co., Ltd.

-

Chugai Pharmaceutical Co., Reported Earnings

Tuesday, October 27, 2026 · 12:00 AM ET

Chugai Pharmaceutical Co., (CHGCY) reported earnings of $0.27 per share on revenue of $2.54 billion for the third quarter ended September 2026. . Revenue grew 12.57% on a year-over-year basis.

CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
$0.27
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth17.4 %
Reported Revenue
$2.54B
Revenue Estimate
—
Revenue Surprise
Revenue Growth12.6 %